Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646451 | 12664645 | 1 | I | 20160812 | 20160818 | 20160818 | EXP | PHHY2016BR112356 | NOVARTIS | 0.00 | F | Y | 50.00000 | KG | 20160818 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646451 | 12664645 | 1 | PS | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 1.5 MG, UNK | 20823 | 1.5 | MG | CAPSULE | |||||||
| 126646451 | 12664645 | 2 | SS | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 3 MG, UNK | 20823 | 3 | MG | CAPSULE | |||||||
| 126646451 | 12664645 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 5 CM2 | 0 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | |||||||
| 126646451 | 12664645 | 4 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 10 CM2, QD | 674210 | 0 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 126646451 | 12664645 | 5 | C | AZOPT | BRINZOLAMIDE | 1 | Ophthalmic | UNK | 0 | SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126646451 | 12664645 | 1 | Dementia Alzheimer's type |
| 126646451 | 12664645 | 3 | Dementia Alzheimer's type |
| 126646451 | 12664645 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126646451 | 12664645 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126646451 | 12664645 | Aspiration bronchial | |
| 126646451 | 12664645 | Dysphagia | |
| 126646451 | 12664645 | Mobility decreased | |
| 126646451 | 12664645 | Pneumonia | |
| 126646451 | 12664645 | Thrombosis | |
| 126646451 | 12664645 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126646451 | 12664645 | 4 | 2009 | 0 |